Amniotic Membrane Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Amniotic Membrane Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

  • December 2021 •
  • 143 pages •
  • Report ID: 6197703 •
  • Format: PDF
The global amniotic membrane market exhibited strong growth during 2015-2020.

Looking forward, the analyst expects the market to grow at a CAGR of around 10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The amniotic membrane (AM) forms the innermost layer of the placenta that is mainly composed of an epithelial monolayer, acellular intermediate basement, and an outer mesenchymal cell layer. It surrounds the embryo/fetus and delimits the amniotic cavity, which is filled with amniotic liquid and assists in healing wounds and protecting against infection. It has anti-inflammatories, anti-bacterial, anti-viral, immunological, anti-angiogenic, and proapoptotic properties. As it also aids in preventing the delivery of nutrients and oxygen to cancer cells and consequently interferes with tumor angiogenesis, growth, and metastasis, AM finds wide applications in oncology across the globe.

Amniotic Membrane Market Trends:
There is currently a rise in the number of corneal surgeries on account of their ability to reduce pain, restore vision, and improve the appearance of a damaged or diseased cornea. This, along with the increasing geriatric population, represents one of the key factors strengthening the growth of the market. AMs assist in enhancing epithelialization, reinforcing adhesion of basal epithelial cells, maintaining epithelial phenotype, and modulating the proliferation of normal cornea, conjunctivital and limbal fibroblast. As they also prevent apoptosis and inhibit scarring, inflammation, and neovascularization, they are widely employed during corneal transplants around the world. Besides this, AMs are relatively cost-effective compared to xenografts and allografts. Consequently, they find extensive applications in a rising number of cosmetic and reconstructive surgeries worldwide. Furthermore, there is a continuous increase in the funding for research and development (R&D) activities in the field of stem cell and regenerative medicine. This, coupled with a rapid increase in the number of surgeries, is creating a favorable market outlook. Other factors, including growing donations of the placenta and rising demand for tissue-based products for treating surgical wounds, are driving the market.

Key Market Segmentation:
the analyst provides an analysis of the key trends in each sub-segment of the global amniotic membrane market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, application and end user.

Breakup by Product:
Cryopreserved Amniotic Membrane
Lyophilization Amniotic Membrane

Breakup by Application:
Surgical Wounds

Breakup by End User:
Ambulatory Surgical Centers
Specialized Clinics
Research Centers and Laboratory

Breakup by Region:
North America
United States
South Korea
United Kingdom
Latin America
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amnio Technology LLC, Amniox Medical Inc. (TissueTech Inc.), Genesis Biologics, Human Regenerative Technologies LLC, Integra LifeSciences Holdings Corporation, Katena Products Inc., MiMedx Group, Next Biosciences, Skye Biologics Holdings LLC, Smith & Nephew plc, Surgenex LLC, Ventris Medical LLC, and Wright Medical Group N.V. (Stryker B.V.). Key Questions Answered in This Report:
How has the global amniotic membrane market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global amniotic membrane market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global amniotic membrane market and who are the key players?
What is the degree of competition in the industry?